The global Drugs for Blau Syndrome market size was valued at US$ 156 million in 2024 and is projected to reach US$ 234 million by 2030, at a CAGR of 7.0% during the forecast period 2024-2030. United States Drugs for Blau Syndrome market size was valued at US$ 67 million in 2024 and is projected to reach US$ 97 million by 2030, at a CAGR of 6.4% during the forecast period 2024-2030.Download FREE ..
